Budget MEPs quiz EU health chief on vaccine policy

2 February 2021
european_commission_large

In a debate on Monday, Budget Committee Members questioned the European Commission’s Health Director General on vaccine availability and the use of the European Union budget.

In her introductory remarks, Sandra Gallina, Director General for Health and Food Safety in the European Commission, explained what the Commission is doing to obtain enough COVID-19 vaccines to reach its objective of having 70% of the EU’s adult population inoculated by the summer. Contracts had to be negotiated rapidly, she said, with liability and indemnification being of paramount importance. The EU has “gone beyond the 12-million-vaccinations mark”, she underlined, saying that “there is no need to envy the US or Israel”.

The Chairman of the Committee on Budgets Johan Van Overtveldt (ECR, BE) emphasised that Members of the European Parliament (MEPs) “did their duty”, by  adopting the Emergency Support Instrument in April and managing  to triple the EU4Health and boost the Horizon Europe research programmes in the negotiations on the EU long-term budget for 2021-2027.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical